Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
5,14 USD | +0,78% | +2,39% | +0,98% |
02/04 | ImmuCell-aandelen dalen na aanvraag van $20 miljoen Gemengde Effecten Shelf | MT |
28/02 | Transcript : ImmuCell Corporation, Q4 2023 Earnings Call, Feb 28, 2024 |
Omzet 2022 | 18,57 mln. 17,37 mln. | Omzet 2023 | 17,47 mln. 16,34 mln. | Marktkapitalisatie | 39,45 mln. 36,9 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -2 mln. -1,87 mln. | Nettowinst (verlies) 2023 | -5 mln. -4,68 mln. | EV/omzet 2022 | 2,91 x |
Nettoschuld 2022 | 6,69 mln. 6,26 mln. | Nettoschuld 2023 | 15,71 mln. 14,69 mln. | EV/omzet 2023 | 3,16 x |
K/w-verhouding 2022 |
-18,9
x | K/w-verhouding 2023 |
-6,79
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 71,37% |
Recentste transcriptie over ImmuCell Corporation
1 dag | +0,78% | ||
1 week | +2,39% | ||
Lopende maand | -3,02% | ||
1 maand | -0,39% | ||
3 maanden | -4,46% | ||
6 maanden | +6,20% | ||
Lopend jaar | +0,98% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Michael Brigham
CEO | Chief Executive Officer | 63 | 01-09-89 |
Bobbi Brockmann
BRD | Director/Board Member | 48 | 01-01-10 |
Corporate Officer/Principal | 68 | 05-04-16 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Michael Brigham
CEO | Chief Executive Officer | 63 | 01-09-89 |
David Tomsche
CHM | Chairman | 67 | 21-12-06 |
Bobbi Brockmann
BRD | Director/Board Member | 48 | 01-01-10 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
26-04-24 | 5,14 | +0,78% | 1 776 |
25-04-24 | 5,1 | +1,19% | 6 409 |
24-04-24 | 5,04 | +0,20% | 7 163 |
22-04-24 | 5,03 | +0,20% | 3 262 |
19-04-24 | 5,02 | -0,59% | 3 187 |
uitgestelde koers Nasdaq, 26 april 2024 om 22:30 uur
Meer koersenVaira. 1 jan. | Kapi. | |
---|---|---|
+0,98% | 39,53 mln. | |
+1,51% | 42,59 mld. | |
+8,57% | 40,65 mld. | |
+49,22% | 40,57 mld. | |
-12,36% | 26,77 mld. | |
+8,92% | 24,81 mld. | |
-25,13% | 18,17 mld. | |
+29,17% | 12,05 mld. | |
-3,12% | 11,7 mld. | |
+6,35% | 11,1 mld. |